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PGC-1αThe tight interrelationship between peroxisomes and mitochondria is illustrated by their cooperation in lipid
metabolism, antiviral innate immunity and shared use of proteins executing organellar ﬁssion. In addition, we
previously reported that disruption of peroxisome biogenesis in hepatocytes severely impacts on mitochondrial
integrity, primarily damaging the inner membrane. Here we investigated the molecular impairments of the
dysfunctionalmitochondria inhepatocyte selective Pex5knockoutmice. First, byusingblue native electrophoresis
and in-gel activity stainingswe showed that the respiratory complexeswere differentially affectedwith reduction
of complexes I and III and incomplete assembly of complex V, whereas complexes II and IV were normally active.
This resulted in impaired oxygen consumption in cultured Pex5−/− hepatocytes. Second, mitochondrial DNA
was depleted causing an imbalance in the expression of mitochondrial- and nuclear-encoded subunits of
the respiratory chain complexes. Third, mitochondrial membranes showed increased permeability and
ﬂuidity despite reduced content of the polyunsaturated fatty acid docosahexaenoic acid. Fourth, the affected
mitochondria in peroxisome deﬁcient hepatocytes displayed increased oxidative stress. Acute deletion of PEX5
in vivo using adeno-Cre virus phenocopied these effects, indicating that mitochondrial perturbations closely
follow the loss of functional peroxisomes in time. Likely to compensate for the functional impairments, the
volume of the mitochondrial compartment was increased several folds. This was not driven by PGC-1α but
mediated by activation of PPARα, possibly through c-myc overexpression. In conclusion, loss of peroxisomal
metabolism in hepatocytes perturbs themitochondrial inner membrane, depletes mitochondrial DNA and causes
mitochondrial biogenesis independent of PGC-1α.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Over the years, it has become clear that peroxisomes and mitochon-
dria have a strong interrelation as they exhibit complementary activi-
ties, share proteins and communicate with each other. Metabolically,
both organelles are involved and cooperate in the degradation of fatty
acids [1,2]. Very long and branched chain fatty acids are shortened in
peroxisomes, followed by transfer to the mitochondria for further
breakdown. Some of the enzymes participating in β-oxidation such as, Department of Pharmaceutical
823, B-3000 Leuven, Belgium.
. Baes).alpha-methylacyl-CoA racemase are targeted to both organelles [3].
Moreover, both peroxisomes andmitochondria contribute to the detox-
iﬁcation of oxygen radicals generated in cellular processes [4]. In addi-
tion, it was recently shown that induction of oxidative stress in
peroxisomes affects the mitochondrial redox balance via unresolved
mechanisms [5]. These organelles also depend on the same proteins
for the execution of their ﬁssion process such as Dlp1, Fis1 and Mff1
[6–9]. A defect in Dlp1 can even lead to a combined peroxisomal–
mitochondrial disorder [10]. Furthermore, other proteins such as MAVS
that are involved in antiviral signaling were shown to reside both on
the peroxisomal and outer mitochondrial membrane [11]. A surprising
ﬁnding was the existence of an intracellular transport route between
mitochondria and peroxisomes whereby mitochondria derived vesicles
can incorporate selected cargo and fuse with peroxisomes [12–14].
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mitochondrial abnormalities arisewhen peroxisomes are dysfunctional.
In a few early reports on Zellweger syndrome, the most severe peroxi-
some biogenesis disorder, mitochondrial abnormalities were docu-
mented in hepatocytes. These changes were not studied in detail but
included structural alterations at the inner mitochondrial membrane
and a reduction in the activities of several complexes of the respiratory
chain [15–19]. Importantly, in different Zellweger syndrome mouse
models generated by disruption of Pex5 [20,21], Pex2 [22], or Pex13
[23], swollen mitochondria with sparse and abnormally shaped cristae
were found in hepatocytes.
Mitochondrial anomalies were also recapitulated in a liver-selective
Pex5 knockout mouse model (L-Pex5−/−) that survives into adulthood
[24]. These mice develop microvesicular steatosis, hepatomegaly, and
ﬁbrosis. The reduced abundance of cristae was accompanied by
impaired activity of complexes I, III and V as determined by spectropho-
tometry and by an energetic deﬁcit leading to the activation of the
cellular energy sensor AMPK [25]. In contrast, mitochondrial matrix
enzymes were more active in mutant hepatocytes as shown for citrate
synthase [24] and mitochondrial β-oxidation [26].
At present, the mechanisms through which peroxisomal inactivity
detrimentally impacts on mitochondrial structure and function are
unresolved. In order to gain insight into these intriguing organellar
interactions, we have investigated in more detail the properties of the
aberrant mitochondria in peroxisome deﬁcient hepatocytes, including
the expression of the respiratory complexes, redox state, lipid composi-
tion, ﬂuidity and permeability of the membranes, and DNA content.
Furthermore, the time course of mitochondrial impairments was investi-
gated by acutely deleting PEX5 fromhepatocytes. Finally, we investigated
whether and how compensatory mitochondrial proliferation is activated.
2. Materials and methods
2.1. Mouse breeding
L-Pex5−/−micewere generated by crossingAlbumin-Cre and Pex5FL/FL
mice as previously described [24]. All experiments were performed
on 8–15-week-old Pex5FL/FL, considered as controls and littermate
L-Pex5−/−mice, unless otherwise stated. Pex5FL/FLmicewere also brought
into a PPARαdeﬁcient background (provided by Prof. F. Gonzalez [27]). In
some experiments Pex5was acutely inactivated in hepatocytes by intra-
venous administration of adenovirus encoding Cre-recombinase
(3.109 pfu) or control adenovirus in Pex5FL/FL PPARα−/− or Pex5FL/FL
PPARα+/+ as previously described [25]. Mice were maintained on a
12-hour light/12-hour dark schedule and were fed standard rodent food
chow and water ad libitum. All animal experiments were approved by
the Institutional Animal Ethical Committee of the University of Leuven.
2.2. Analysis of mitochondria
2.2.1. Puriﬁcation of mitochondria
L-Pex5−/− andwild-typemicewere sacriﬁced by cervical dislocation
and livers were rapidly removed, washed in ice-cold homogenization
medium (HM) (0.25 M sucrose, 5 mM Mops, 1 mM EDTA, 0.1% (v/v)
ethanol, pH 7.2), minced and homogenized in a Potter homogenizer
with a motor-driven pestle (1200 rpm). Cellular debris was pelleted
by centrifugation of the homogenate at 770 g for 10 min. The post-
nuclear supernatant (PNS) was spun for 10min at 2330 g and the pellet
was washed once to obtain a fraction enriched in mitochondria. For
some experiments, this fraction, corresponding to 1.5 g of liver, was
layered on top of a Percoll solution (40% (w/v) Percoll, 0.22 M sucrose,
1 mM Mops, 1 mM EDTA, 0.1% (v/v) ethanol, pH7.2) and centrifuged
for 1 h at 4 °C at 34,000 g (Beckmann ultracentrifuge) as described be-
fore [28] but using only 18 ml of Percoll solution. Subsequently, 500 μl
fractions were collected starting from the bottom. The distribution of
the organelles was monitored by measurement of marker enzymes[mitochondria (glutamate dehydrogenase, GDH); lysosomes (acid
phosphatase); endoplasmic reticulum (glucose-6-phosphatase)]. Mito-
chondrial enzymes were recovered in fractions 2–22 of the 38 fractions
thatwere collected. The 5 fractions containing the highest activity of the
mitochondrialmarker enzyme GDHwere combined, diluted 20 times in
HM, and centrifuged (10 min, 4 °C, 2330 g). Based onWestern blot and
EM analysis these fractions primarily containedmitochondria and were
only contaminated to a minor extent with peroxisomes, ER or lyso-
somes. The puriﬁed mitochondrial pellet was resuspended in 1 ml of
HM and used immediately or stored at−80 °C for further analysis.
2.2.2. Quantiﬁcation of mitochondria
Puriﬁedmitochondriawere counted on a FACSCanto ﬂow cytometer
(BD) using BD TrucountTM tubes.
2.2.3. Electron microscopy on isolated mitochondria
The Percoll-puriﬁed mitochondrial pellet was resuspended in a cell
free system (CFS) buffer (10 mMHEPES, 220 mMmannitol, 68 mM su-
crose, 2 mMNaCl, 5 mM pyruvate, 0.5 mM EGTA, 2 mMMgCl2, 2.5 mM
KH2PO4, pH 7.4), centrifuged for 3 min, and ﬁxed in freshly prepared 4%
(w/w) glutaraldehyde and 8% (w/v) BSA in CFS buffer for 30min on ice.
The pellet was washed with sodium cacodylate buffer supplemented
with 1% (w/v) CaCl2 and prepared for electron microscopy.
2.2.4. Blue native gel electrophoresis of the oxidative phosphorylation
(OXPHOS) complexes
Blue native gel electrophoresis followed by in-gel activity staining
was performed as described [29] on isolated liver mitochondria. Sam-
ples of controls and knockouts were loaded in duplicate (60 μg/lane).
In the ﬁrst set of lanes, activity staining of complexes I, III and IV was
performed, and the second set of laneswas used for the activity staining
of complexes II and V. The bands resulting from complexes I, II, III and IV
activities were scanned in transmission mode. The complex V band,
which was seen as a white precipitate, was scanned in ‘reﬂexion’
mode using a dark background for better visualization [29].
2.2.5. Mitochondrial transmembrane potential
The membrane potential of puriﬁed mitochondria was analyzed
essentially as in [30]. Brieﬂy, puriﬁed mitochondrial suspensions were
incubated in medium (110 mM KCl, 75 mM mannitol, 20 mM MOPS,
10 mM glutamate, 1 mM malate, 1 mM EGTA, albumin 1 mg/ml,
pH 7.2) for 1 min at room temperature in the dark with JC-1 (1.5 μg/mg
protein) in a ﬁnal volume of 0.5 ml. Suspensions were analyzed immedi-
ately using a FACSVantage SEﬂow cytometer (BD) equippedwith a single
488 argon laser. The ﬁlter in front of the ﬂuorescence 1 (FL1) photo
multiplier (PMT) transmits at 530 nm and has a bandwidth of 30 nm,
and the ﬁlter used in the FL2 channel transmits at 585 and has a band-
width of 42 nm. To analyze mitochondria stained with JC-1, the PMT
value of the detector in both FL1 FL2 PMT was set at 480 V; FL1–FL2
compensation was 1.6%, and FL2–FL1 compensation was 30%.
2.2.6. Measurement of ﬂuorescence anisotropy
Mitochondrialmembrane ﬂuiditywas evaluated byﬂuorescence an-
isotropy of themitochondria-bound dyes 1,6-diphenyl 1,3,5-hexatriene
(DPH) and trimethylammonium (TMA)-DPH according to [31]. Freshly
prepared mitochondrial suspensions (0.5 mg/ml) were incubated in
Standard Incubation Medium (SIM; 200 mM sucrose, 10 mM Tris–HCl,
1 mM KH2PO4, 10 μM EGTA, 3 μM rotenone, 0.5 μg oligomycine and
5 mM succinate; pH 7.4) either with DPH (50 μM; diluted from a stock
solution of 20 mM (prepared in tetrahydrofuran) with 10 mM Tris–HCl
pH 7.4, 150 mM KCl, 1 mM EDTA) or TMA-DPH (3 μM) for 30 min at
37 °C, under continuous stirring. Steady-state ﬂuorescence polarization
was measured in a Hitachi spectroﬂuorometer (ex 366 nm: em
425 nm). The results are expressed as anisotropy units (r), where r =
(I0/I90) / (I0 + 2I90). I0 and I90 represent the intensities of light when
polarizers were in parallel or in perpendicular orientations, respectively.
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made by subtracting the signal obtained from identical but unlabeled
samples and the ﬂuorescence of the buffer plus label alone.
2.2.7. Lipid analysis
Lipid extracts were prepared from Percoll-puriﬁed mitochondria
and separated by thin-layer chromatography using heptane/ether/
acetic acid (70/30/1, v/v) before enzymatic analysis of triacylglycerols
[32], cholesterol and cholesterylesters [33]. Phospholipids were sepa-
rated by thin-layer chromatography with chloroform/methanol/acetic
acid/formic acid/water (70:30:12:4:2, v/v) as developing solvent [34].
Major spots corresponding to phosphatidylcholine (PC), phosphatidyl-
ethanolamine (PE), cardiolipin (CL), phosphatidylserine (PS) and phos-
phatidylinositol (PI) were visualized with iodine vapor, ninhydrin
staining and phosphate staining, scraped and phosphorus content was
determined. Ceramides were quantiﬁed with recombinant ceramide
kinase in presence of 32P-ATP [35,36].
Total fatty acid composition was determined in lipid extracts or in
phospholipids extracted from scraped silica with chloroform/methanol
(1:1,v/v) by acidic transmethylation and gas chromatography (SPB-
PUFA column; Varian 3800). Individual fatty acids were identiﬁed by
comparing each peak's retention time to those of external standards,
and were expressed as the mol% of total fatty acids.
2.2.8. Estimation of mitochondrial size
EM micrographs of 3 control and L-Pex5 knockout mouse livers at a
magniﬁcation of 5200 were used to measure the mitochondrial surface
area using the program ImageJ 2.0 (NIH, USA). The values are expressed
as Mean ± SEM.
2.3. RNA analysis
2.3.1. Quantitative real-time RT-PCR
qRT-PCR was performed as described previously [37] using an ABI
PRISM 7500 Real Time PCR instrument (Applied Biosystems, Lennik,
Belgium) and probes labeledwith theﬂuorescent dye FAMand quench-
er TAMRA. Primers and probes were designed using Primer Express
Software (Applied Biosystems, Lennik, Belgium) (Supplemental
Table 1). Relative expression levels of the target genes were calculated
taking into account the ampliﬁcation efﬁciency as described [38]. The
relative expression levels of the target genes were calculated as a ratio
to the housekeeping gene β-actin.
2.3.2. Microarray analysis
The transcriptional proﬁles of livers of 10-week-old control and
L-Pex5−/− mice (n = 3) were analyzed by using the whole genome
Affymetrix GeneChip® Mouse Genome 430 2.0 Array as described
previously [39]. Labeling of the samples, hybridization, washing and
scanning of the chips were carried out at the MicroArray Facility in
Leuven (MAF, Leuven, Belgium). The complete dataset is available
under GEO record GSE27720.
2.4. Mitochondrial DNA copy number
Nuclear andmitochondrial DNAwere isolated from liver tissue using
a DNeasy kit (Qiagen). To quantify the mitochondrial DNA (mtDNA)/
nuclear DNA (nDNA) ratio, qPCR analysis was performed using primers
and probes for the gene encodingmitochondrial 16S ribosomal RNAand
nuclear encoded Mpeg, a gene expressed in macrophages (Supplemen-
tal Table 1).
2.5. Protein analysis
2.5.1. Western blotting
Western blotting was performed as described previously [40]. HRP-
labeled secondary antibodies were used and detection was performedusing the ECL plus detection kit (Amersham). The following primary an-
tibodies were used: COX1 (Mitosciences, Abcam), TOM20 (Santa Cruz),
VDAC1 (Cell Signaling) and β-actin (Cell Signaling).
2.5.2. Enzyme activity
Glutamate dehydrogenase (GDH), complex I and citrate syn-
thase activities were measured in liver homogenates as de-
scribed [24]. In order to evaluate the quality/integrity of the
Percoll-puriﬁed mitochondria, GDH activity was measured in
the presence and absence of a detergent. For total GDH activi-
ties, mitochondria were pre-incubated with 0.017% CHAPS (3-
[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate)
for 1 min to destroy mitochondrial membrane barriers.
2.6. In vitro analysis
2.6.1. Isolation of primary hepatocytes
Hepatocytes were isolated using a two-step collagenase perfusion
technique, plated, and cultured as previously described [26]. For some
experiments, primary hepatocytes were infected either 4 h after plating
with adenovirus encoding PGC-1α (MOI = 30) [25] or before plating
with lentivirus encodingmitochondrial roGFP2 (mt-roGFP2) (MOI=5).
2.6.2. Extracellular ﬂux analysis
Primary hepatocytes, plated at 10,000 cells per well, were analyzed
24 h after plating using a Seahorse XF24 ﬂux analyzer (Seahorse
Bioscience) as previously described [41]. Oxygen consumption rate
(OCR), a measure for electron transport and oxidative phosphorylation,
was recorded.
2.6.3. Redox state of mitochondria
Isolated primary hepatocytes from control and L-Pex5−/−mice were
cultured in 35 mm FluoroDishes (World Precision Instruments, Hert-
fordshire, England), at a density of 0.5 million cells/dish. To measure
superoxide content, hepatocytes were stained after 24 h with MitoSOX
Red (5 μM, 15min), washedwith PBS, and subsequently incubatedwith
MitoTracker Green (250 nM, 20 min) at 37 °C in growth medium. After
washing with PBS, medium was refreshed and images were acquired
immediately. Absorption/emission maxima for MitoSOX Red and
MitoTracker Green were 510/580 nm and 490/516 nm, respectively.
As MitoTracker Green stains all the mitochondria irrespective of their
redox or membrane potential, the ratio of ﬂuorescent intensities of
MitoSOX Red/MitoTracker Green was used for normalization purposes.
In two independent experiments, 10 different cells of each genotype
were evaluated in which 10 regions of interest per cell were selected.
To monitor the mitochondrial glutathione redox state a lentiviral
vector encodingmt-roGFP2 was generated based on a template provid-
ed by Dr. Jim Remington (University of Oregon) [42]. Isolated hepato-
cytes from control and L-Pex5−/− mice were transduced immediately
after isolation at a MOI of 5 and cultured in 35/14 mm glass bottom
dishes (MatTek corporation, Ashland, USA). After 24 h, media were
refreshed and – 24 h later – images were acquired at the excitation
wavelengths of 400 and 480 nm as described elsewhere [5]. The ratio
of ﬂuorescent intensities at 400 to 480 nm can be used as a readout of
the glutathione redox environment in the organelle. In three indepen-
dent experiments, 10–15 different cells of each genotype were evaluat-
ed in which 10 regions of interest per cell were selected.
All the images were acquired with a motorized inverted IX-81 mi-
croscope connected to a CCD-FV2T digital camera (Olympus, Aartselaar,
Belgium) and analyzed as previously described [5].
2.7. Statistics
The unpaired two-sided Student's t-test or two-way ANOVA follow-
ed by Bonferroni was used to compare the results obtained for both
groups of mice.
288 A. Peeters et al. / Biochimica et Biophysica Acta 1853 (2015) 285–2983. Results
3.1. Defective respiratory chain complexes I, III and V cause impaired
mitochondrial respiration in L-Pex5 knockout hepatocytes
We previously determined by spectrophotometric analyses that the
ultrastructural anomalies of the mitochondrial inner membrane in
livers of L-Pex5−/−micewere accompanied by profoundly impaired ac-
tivities of complex I (to ~20% of control), mild reduction of complexes III
and V (~60% of control), whereas complexes II and IV were unaltered
[24]. This raised the question whether the affected respiratory com-
plexeswere present but not functional, or alternatively, whether the as-
sembly/stability of these complexes was compromised. To visualize
OXPHOS complexes, blue native gel electrophoresis was performed on
isolated liver mitochondria. This revealed a reduction in protein levels
of complexes I, III and V in the L-Pex5−/− livers (Fig. 1a) whereas the
protein bands of complex II and complex IV were hardly detectable in
both wild-type and knockout mitochondria (Fig. 1a).
To better visualize the complexes and monitor their functionality,
in-gel activity stainingswere conducted. In agreementwith the spectro-
photometric analyses, complexes II (Fig. 1b right panel) and IV (Fig. 1b
left panel) showed substantial in-gel activity in the knockout liver
although the mobility of these complexes was reduced. Furthermore,
the activity of complex III was undetectable in mitochondria from
L-Pex5−/− livers whereas this was low but clearly present in mitochon-
dria from control mice (Fig. 1b left panel). Surprisingly however,
although the in-gel activity analyses do not allow precise quantiﬁcation,
complex I activity was only moderately reduced, which is in contrast to
the spectrophotometric data. An additional striking ﬁnding was that
complex V activity was primarily present in several catalytically active
subcomplexes (Fig. 1b right panel). Such F1 subcomplexes were previ-
ously found in patients with mitochondrial disorders [29,43]. Notably,
F1 subcomplexes can be more active than the holo-complex due to
the absence of the inhibitor protein IF1 [43]. These data indicate
that the residual complex V activity, previously measured by spectro-
photometric analysis, was largely attributable to catalytically active
subcomplexes that can synthesize ATP but are unable to transport
protons.
To investigate the impact of the respiratory complex impairments on
O2 consumption, hepatocytes from control and L-Pex5−/− livers were
tested in a Seahorse XF24 ﬂux analyzer. Under baseline conditions, the
oxygen consumption rate (OCR) was signiﬁcantly lower in L-Pex5−/−
than in wild-type hepatocytes (Fig. 1c). After addition of antimycin A,
an inhibitor of complex III that completely inhibits mitochondrial respi-
ration, oxygen consumption signiﬁcantly dropped in wild-type hepato-
cytes, but this inhibitor had little effect on L-Pex5−/− hepatocytes,
indicating that mitochondrial respiration was already reduced to mini-
mal levels.
3.2. Expression of mitochondrially-encoded subunits and mitochondrial
DNA content is impaired
To investigate the origin of the differential depletion of the respirato-
ry complexes, the expression of a selected set of subunits encoded by
the nuclear and mitochondrial genome was determined by microarray,
qRT-PCR andWestern blot analysis. Based on previously generated mi-
croarray data [25,44], the transcripts of nuclear-encoded subunits were
either unaltered or increased (Supplemental Table 2). In contrast, qRT-
PCR analysis revealed that transcripts of the mitochondrially-encoded
ND1 (complex I), COX2 (complex IV) and ATP6 (complex V) were all
signiﬁcantly suppressed (Fig. 2a). This was conﬁrmed at the protein
level by reduced expression of COX1 (data not shown). Because a con-
certed decrease of mitochondrially-encoded mRNAs can be the result
of a reduction of mitochondrial DNA, we determined the ratio of
mtDNA/nuclear DNA. In Pex5−/− livers this ratio was halved compared
to littermate controls (Fig. 2b). Taken together, loss of mtDNA impairedthe expression of mitochondrially-encoded subunits, which contrasts
with the normal to increased transcript levels of nuclear-encoded
subunits.
3.3. The mitochondrial compartment is enlarged in peroxisome deﬁcient
liver
Several observations, including the electron microscopy data show-
ing clusters ofmitochondria [24] and the increased activity ofmitochon-
drial matrix enzymes [24,26], suggested that the volume of the
mitochondrial compartment was increased in hepatocytes of L-Pex5
knockout mice. In order to better document this phenomenon, mito-
chondria were puriﬁed by differential and Percoll gradient centrifuga-
tion. As shown in Fig. 3a, the peak of the mitochondrial GDH activity
shifted to lower density fractions in the knockout preparations, likely
reﬂecting their aberrant morphology. Both from control and knockout
preparations, we used the ﬁve fractions containing the highest GDH
activity for further experiments.
The enlargement of the mitochondrial compartment in peroxisome
deﬁcient hepatocytes was proven by several lines of evidence. First,
the pellet containing the mitochondria isolated from Pex5 knockout
livers was considerably larger (0.17 ± 0.03 g/g liver vs 0.10 ± 0.01 g/g
liver in wild-type; n = 6, p b 0.05) and contained more protein (19 ±
2 mg/g liver vs 12 ± 1.5 mg/g liver for wild-type, n = 6, p b 0.05) and
phospholipids (3.6 ± 0.3 μmol/g liver vs 1.4 ± 0.3 μmol/g liver, n = 6,
p b 0.001). Interestingly, the ratio of phospholipids/protein was signiﬁ-
cantly increased (189.9 ± 3.4 nmol/mg proteins for knockout vs
115.6± 4.2 nmol/mg proteins forwild-type; n=6, p b 0.001), probably
pointing to an altered content of the mitochondrial compartment. This
increase in mass of isolated mitochondria was not caused by a larger
size of individual mitochondria in the knockout liver as estimated by
measuring the surface area of mitochondria on electron micrographs
(Fig. 3b). Second, counting of puriﬁedmitochondria using FACS analysis
yielded a 3-fold higher number of mitochondria than controls (Fig. 3c).
Third, in linewith these ﬁndings,microarray analysis revealed increased
expression of genes encoding several mitochondrial matrix (citrate
synthase, malate dehydrogenase 2, Isocitrate dehydrogenase 2) and
membrane proteins (including TOM20, TIM10, prohibitin, CPT2), as
shown in Supplemental Table 2. This was further conﬁrmed by a 2–4
fold increase in the activity per g liver for mitochondrial matrix
enzymes, GDH and citrate synthase, and the increased protein levels of
outer mitochondrial membrane proteins TOM20 and VDAC1 using
Western blot analysis (Fig. 3d). Thus, the increased number of mito-
chondria is in sharp contrast with the reduced level of mtDNA/nuclear
DNA, implying that the amount of DNA per mitochondrion is severely
depleted.
3.4.Mitochondria isolated from L-Pex5 knockoutmice retain their structural
and functional abnormalities
To further characterize the features of isolated mitochondria from
peroxisome deﬁcient livers, we performed additional structural and
functional tests. Electron microscopic analysis of Percoll puriﬁed mito-
chondrial fractions revealed that mitochondria from wild-type mice
were present in either an orthodox or condensed conﬁguration
(Fig. 4a), reﬂecting respectively metabolic states III and IV [45–47]. In
contrast, mitochondria from L-Pex5 knockout livers were not found in
either conformation. In some mitochondria, the matrix was reduced to
a concentric ring, and large empty spaces, presumably intermembrane
space, could be observed (Fig. 4a).
Subsequently, we tested whether Percoll puriﬁed mitochondria
still showed a reduction of the mitochondrial membrane potential,
as previously observed in primary hepatocytes from L-Pex5 knockout
mice [24]. After incubating freshly puriﬁed mitochondria with JC1,
almost all control mitochondria displayed a high membrane poten-
tial (Fig. 4b). In clear contrast, almost all knockout mitochondria
a
Ct              M           L-Pex5-/-
complex I
complex V
complex III
complex IV
complex II
c
b Ct                      L-Pex5-/- Ct                      L-Pex5-/-
Fig. 1.Differential reduction of OXPHOS complexes causes impaired respiration in Pex5−/− hepatocytes. a: Blue native gel electrophoresis shows reduced protein levels of complexes I, III
and V in Pex5−/− liver mitochondria (red arrows). LaneM contains a human skeletal muscle control sample. Complexes II and IV are difﬁcult to identify in the liver samples and run with
slightly lowermobility as compared to themuscle sample. Representative experiment out of 2with similar results. b: In-gel activity staining of respiratory complexes. Left: the function of
complex I is moderately reduced whereas complex III is not detectable in Pex5−/− liver mitochondria. The blue band above complex III in the control samples represents complex V from
the Coomassie staining after blue native electrophoresis. Complex IV is active but displays impaired mobility. Right: the majority of complex V activity is present in lower MW
subcomplexes (red arrows) while complex II displays normal function but slightly impaired and variable mobility. Representative experiment out of 4 with similar results. c: Oxygen
consumptionwasmeasured in primary hepatocytes. The proﬁles shown are from 1 experiment inwhich 10 replicate wells weremonitored from either wild type or Pex5−/− hepatocytes.
Pex5−/− hepatocytes consume less oxygen and oxygen consumption is insensitive to the complex III inhibitor antimycin A. Values are shown as mean ± SEM. p b 0.001: ***; p b 0.01: **
L-Pex5−/− versus control mice.
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potential. In addition, complex I activity measured by spectrophoto-
metric analysis was undetectable in knockout mitochondria (wild-
type values: 0.125 U/mg protein). Thus, pure mitochondrial
fractions retained the functional anomalies seen in vivo and in cell
culture.3.5. Puriﬁed mitochondria of L-Pex5 knockout mice display increased
membrane ﬂuidity
The shift in the sedimentation of the knockout mitochondria in
Percoll gradients reﬂects a change in buoyant density, caused either
by changes in the composition and/or by altered permeability of the
Fig. 2. Reduced expression ofmitochondrial-encoded subunits of OXPHOS complexes and
of mtDNA in L-Pex5−/−mice. a: Transcript levels of the mitochondrial-encoded subunits
ND1 (complex I), COX2 (complex IV) and ATP6 (complex V) were signiﬁcantly lower in
Pex5−/− livers as compared to controls (Ct). b: Mitochondrial DNA copy number, relative
to genomic DNA, was reduced in Pex5−/− livers. Values are shown as mean ± SEM for
n ≥ 4. p b 0.01: **; p b 0.05: * L-Pex5−/− versus control mice.
290 A. Peeters et al. / Biochimica et Biophysica Acta 1853 (2015) 285–298inner membrane. In order to evaluate the integrity of the isolated mito-
chondria, GDH activity was measured in the presence and absence of
detergents. A large amount appeared to be non-latent (Fig. 4c) pointing
to changes in the dynamics of the mitochondrial membrane.
To obtain a more direct readout of the mitochondrial membrane
ﬂuidity, we analyzed the changes in the steady state ﬂuorescence polar-
ization of mitochondria bound to DPH (a ﬂuorescent dye that is readily
incorporated in the hydrophobic region of the phospholipid bilayer) or
TMA-DPH (a ﬂuorescent probe, which becomes incorporated in the
membrane surface between the phospholipid headgroups). The rota-
tional diffusion freedom of these probes was monitored by measuring
the extent of depolarization of the exciting polarized light [48].
Percoll-puriﬁed knockout mitochondria showed lower ﬂuorescence
polarization of DPH as compared to control mitochondria (Fig. 4d).
Similar results were obtained using TMA-DPH (data not shown).
These results indicate that the mitochondrial membrane ﬂuidity and
thus mitochondrial membrane dynamics were abnormally increased
in Pex5 knockout mitochondria.
3.6. The lipid composition of mitochondrial membranes is altered in
peroxisome deﬁcient hepatocytes
Sincemembraneﬂuidity is strongly inﬂuenced by changes in choles-
terol content and fatty acid composition of the membrane [49–51],
lipidomic analysis of the Percoll-puriﬁed mitochondria was performed.
The stoichiometry of the major membrane components was deter-
mined. Despite normal cholesterol content in total liver, the ratio of
cholesterol per phospholipid was decreased in knockout compared to
control mitochondria (10.0 ± 0.5 vs 12.6 ± 0.6 nmol/100 nmol phos-
pholipid; n= 4, p b 0.05), in linewith the increasedmembrane ﬂuidity.
Ceramide levels did however not statistically differ between control andknockout mitochondria (82 ± 9 vs 68 ± 13 pmol/nmol phospholipid,
respectively). Subsequently, we quantiﬁed the relative amounts of
the different phospholipid classes. The proportion of phosphatidyl-
choline (PC), phosphatidylethanolamine (PE), cardiolipin (CL),
phosphatidylserine (PS) or phosphatidylinositol (PI) was not sig-
niﬁcantly altered (Fig. 4e). Lysophospholipids, known to affect
the membrane permeability, were not detected by thin layer
chromatography.
Finally, the fatty acid composition of Percoll-puriﬁed mitochondria
and of the phospholipids PC, PE and CL was determined using GC anal-
ysis (Supplemental Table 3). In general, the balance between saturated,
monounsaturated, and polyunsaturated fatty acids did not differ much
between control and knockout mitochondria. However, some major
changes in individual fatty acids were found in all samples examined.
Docosahexaenoic acid levels (DHA, C22:6n−3) were reduced by 80% in
puriﬁed knockout mitochondria and in all major phospholipid classes.
This can be ascribed to the inactivity of peroxisomal β-oxidation, neces-
sary for theﬁnal step in the synthesis of this compound. Thiswas accom-
panied by a compensatory increase of C18:2 levels. The replacement of a
PUFA with a di-unsaturated fatty acid in fact reduces the double bond
index and is in conﬂict with increased ﬂuidity of the mitochondrial
membrane.
3.7. Increased oxidative stress in mitochondria of peroxisome deﬁcient
hepatocytes
Malfunctioning of the respiratory chain can be accompanied
by altered production of ROS and oxidative stress. Previously, we
did not ﬁnd evidence for oxidative stress development in Pex5−/−
hepatocytes based on measurements of peroxide levels with
dichlorodihydroﬂuorescein diacetate in isolated hepatocytes [24].
To speciﬁcally evaluate the redox state of mitochondria, we now
used more targeted and speciﬁc probes. First, to detect superoxide
levels, the most common ROS species generated in mitochondria
[52], cultured hepatocytes were incubated with MitoSOX Red. This
analysis revealed that the ﬂuorescence signal was signiﬁcantly
lower in knockout than control mitochondria (Fig. 5a). However,
this is likely due to impaired uptake of the probe in mitochondria
as a result of the reduced membrane potential. Subsequently, mt-
roGFP2, a mitochondrially targeted glutathione redox sensor [42],
was transduced in mitochondria of control and Pex5−/− hepatocytes
by lentiviral infection. This analysis showed a signiﬁcant increase of
the mitochondrial redox state in knockout hepatocytes (Fig. 5b),
indicating that the mitochondrial anomalies were accompanied by
increased oxidative stress.
3.8. Acute elimination of peroxisomes causes similar mitochondrial
alterations
All the above experimentswere performed using livers of adultmice
in which peroxisomal function was chronically deleted from hepato-
cytes since birth [24]. To exclude the possibility that these results
reﬂected a long-term adaptation to the peroxisome deﬁciency state,
we also acutely eliminated PEX5 in hepatocytes. This also allowed us
to delineate the timing of mitochondrial anomalies subsequent to loss
of peroxisomal function. To this end adenoviral Cre recombinase was
administered to Pex5FL/FL mice, using previously described methods
[25]. Upon deletion of PEX5, no new functional peroxisomes can be
formed and the existing peroxisomes disappear with an estimated
2-day half-life [53]. By monitoring urate oxidase, the activity of which
strongly depends on its peroxisomal localization, we observed that
7 days after induction of PEX5 deletion, functional peroxisomes had
partially disappeared. One week later, the majority of hepatocytes was
devoid of intact peroxisomes (Fig. 6a). Thiswas conﬁrmed by the cytosol-
ic staining pattern of the peroxisomal marker enzyme catalase (data
not shown).
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Fig. 3. Themitochondrial compartment is enlarged in L-Pex5−/−mice. a: Percoll gradient of mitochondrial-enriched fraction obtained by differential centrifugation of livers from control
(Ct) and L-Pex5−/− liver. The GDH-activity in the ﬁrst 22 Percoll fractions is shown in U/mg protein. The total GDH-activity was increased in isolatedmitochondria of L-Pex5−/−mice and
the peak of GDH activity shifted towards lower density fractions (1 representative experiment out of 4 is shown). b: Mitochondrial area was estimated on electron micrographs at a
magniﬁcation of 5200 folds by using the ImageJ program. All values are represented as mean ± SEM of arbitrary units (n = 260 and 160 mitochondria from 3 independent control
and L-Pex5 knockout mice respectively, p b 0.05); c: Mitochondrial number, determined by FACS analysis, was strongly increased in L-Pex5−/− mice. Values shown are mean ± SEM
(n= 4, *p b 0.05) d: Western blot analysis of the outer mitochondrial membrane proteins TOM20 and VDAC1 shows increased expression relative to β-actin in L-Pex5−/− liver as com-
pared to control. Numbers at the top of the blots indicate the fold change as quantiﬁed after normalizationwith β-actin. All values are shown asmean±SEM (n=3). p b 0.01: **; p b 0.05:
* L-Pex5−/− versus control mice.
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of peroxisomes in hepatocytes induced similar mitochondrial defects as
chronic loss, further highlighting that these defects were primary in na-
ture. This analysis revealed that the activity of complex I, measured by
spectrophotometry, and expression levels of COX2 and ND1 were still
normal one week after adenoviral Cre administration. However, after
two weeks, complex I activity was strongly impaired (2.5 ± 0.2 mU/mg
protein after injection of adenoviral Cre-recombinase versus 8.0 ±0.3 mU/mg protein with control virus) (Fig. 6b, left columns). In
addition, expression of COX2 and ND1 (Fig. 6c) and themtDNA abun-
dance (Fig. 6d) were signiﬁcantly decreased at this time point. This
was accompanied by ultrastructural abnormalities of mitochondria
similar to those in L-Pex5 knockout livers (data not shown). The
mitochondrial anomalies were thus not a long-term adaptation to
the absence of functional peroxisomes as they occurred rapidly
after peroxisome deletion.
L-Pex5-/-Ct
Ct L-Pex5-/-
a
b
e
dc
Fig. 4. Characteristics of Percoll-puriﬁed mitochondria of L-Pex5−/− mice. a: EM analysis of GDH-enriched Percoll fractions. Wild-type mitochondria are either in the condensed or
orthodox state (marked with X in Ct), while none of the mitochondria from mutant hepatocytes can be found in either state. Unusual conformations of mitochondria from mutant
liver are marked with X. b: FACS-scan analysis of the mitochondrial membrane potential. The majority of the wild-type mitochondria display a red ﬂuorescence, while KOmitochondria
mainly display a green ﬂuorescent signal. The data in this ﬁgure are from one experiment out of 4with similar results. c: Non-latent activitymeasurement of GDH. Values are expressed as
% of total GDH-activity ± SEM (n= 5). d: Anisotropymeasurements using DPH as ﬂuorescent probe shows increased ﬂuidity of mitochondrial membranes from L-Pex5−/−mice (n= 3).
e: The phospholipid composition ofmitochondria is not signiﬁcantly different in L-Pex5−/− compared to controlmice. Values are expressed relative to the total amount of phospholipids±
SEM (n= 4). PC: phosphatidylcholine, PI: phosphatidylinositol, PS: phosphatidylserine, PE: phosphatidylethanolamine, CL: cardiolipin. p b 0.001: ***; p b 0.05: * L-Pex5−/− versus control
mice.
292 A. Peeters et al. / Biochimica et Biophysica Acta 1853 (2015) 285–298
Fig. 5. Increased redox state ofmitochondria in peroxisome-deﬁcient hepatocytes. a: Ratio
of ﬂuorescent intensities of MitoSOX Red (MSR) to mitotracker green (MTG) in primary
hepatocytes isolated from control (Ct) and L-Pex5−/− mice (n ≥ 200 regions of interest
for each genotype derived from 2 independent experiments). b: Increased mitochondrial
glutathione redox balance in L-Pex5−/− primary hepatocytes compared to control
hepatocytes as observed by the ratio of ﬂuorescence intensities at 400- and 480-nm exci-
tation wavelengths of mt-roGFP2 (n ≥ 450 regions of interest for each genotype derived
from 3 independent experiments). Values are expressed as mean ± SEM. p b 0.001: ***
L-Pex5−/− versus control mice.
Fig. 6. Acute deletion of PEX5 affects the respiratory chain and mtDNA. a: The declining
activity of urate oxidase in liver homogenates of Pex5FL/FL mice 7 and 14 days after
administration of adenoviral Cre versus control virus is indicative of impaired peroxisomal
function. b–d: Analyses of mitochondrial markers in liver of Pex5FL/FL mice 14 days after
administration of adenoviral Cre or control virus. The activity of complex I (b), transcript
levels of the mitochondrial-encoded subunits COX2 and ND1 (c) and the ratio of
mtDNA/nuclear DNA (d) were signiﬁcantly decreased in mice treated with adenoviral
Cre. Values are expressed as mean ± SEM. p b 0.001: ***; p b 0.05: * control virus versus
adenoviral Cre.
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PEX5 elimination is not driven by PGC1α but is mediated by PPARα
Given that PGC-1α is amajor driver of mitochondrial biogenesis and
oxidative capacity in conditions of energy deﬁcit by inducing and co-
activating crucial transcription factors, it was surprising that transcript
and protein levels of PGC-1α were reduced ([25] and Fig. 7a) in mice
with either a chronic or acute elimination of PEX5 (30–50% of WT). To
obtain insight in the mechanisms causing the enlargement of the mito-
chondrial compartment, we analyzed the expression of other factors,
known to be involved in the regulation of mitochondrial proliferation,
respiration or transcription [54] by using qRT-PCR analysis (Fig. 7a)
and analyzing micro-array data of L-Pex5−/− livers (Supplemental
Table 2).
The expression of the other PGC family members, PGC-1β and PRC1
was unaltered. Also the transcription factors NRF-1 and NRF-2 that co-
ordinate the expression of nuclear-encoded mitochondrial proteins
and themitochondrial transcriptional machinery, and factors that regu-
late mitochondrial transcription (mitochondrial RNA polymerase andthe mitochondrial transcription factor A (TFAM), B1 and B2) were not
changed to a signiﬁcant extent. Notably, transcripts of C-MYC, known
to regulate mitochondrial biogenesis [55], were 7-fold increased in
Fig. 7.Mitochondrial proliferation in L-Pex5−/− livers occurs despite reduced levels of PGC-1α but depends on PPARα. a: qRT-PCR analysis of key regulators of mitochondrial biogenesis
and transcription in L-Pex5−/−micewith chronic deletion of PEX5. b: Citrate synthase activity is increased 14days after acute deletion of PEX5with adenoviral Cre recombinase in Pex5FL/FL
mice but not in a PPARα−/− background indicating that mitochondrial proliferation depends on PPARα. c–e: qRT-PCR analysis of regulators of mitochondrial biogenesis and transcription
in PPARα+/+Pex5FL/FL or PPARα−/−Pex5FL/FLmice 14days after administering adenoviral Cre recombinase. All values are shownasmean±SEM (n=4) p b 0.001: ***; p b 0.01: **; p b 0.05: *
knockout versus respective control mice.
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changed based onmicro-array analysis, a signiﬁcant 1.6 fold increase
was noticed by qPCR.
In order to further substantiate these data, mitochondrial biogenesis
was also examined inmouse liverswith acute elimination of PEX5 using
adenoviral Cre recombinase. Notably, mitochondrial expansion was
already observed two weeks after induction of Pex5 recombination as
evident from increased activity of citrate synthase (Fig. 7b). The expres-
sion levels of NRF2 (1.7 folds) and C-MYC (3 folds) were signiﬁcantly
increased in these livers (Fig. 7c-d), whereas NRF1 and ERRα wereunaltered (data not shown) and TFAM was even reduced (Fig. 7e)
(to 70% of control).
Interestingly, c-myc is known to be induced by PPARα agonists [56]
and this nuclear receptor is strongly activated in L-Pex5−/− livers [25]. In
order to investigate whether PPARα activation was involved in the
development of the mitochondrial alterations, a mouse strain was
generatedwith peroxisome deﬁcient hepatocytes in a PPARα null back-
ground. Therefore, adenoviral Cre-recombinase was administered to
PPARα−/−Pex5FL/FL mice and, as controls, to PPARα+/+Pex5FL/FL mice. In
the PPARα deﬁcient background, mitochondria were not proliferating
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oxisomes are eliminated, based on normal citrate synthase activity
(Fig. 7b). Under these circumstances, c-myc transcripts were not in-
creased in PEX5 deleted hepatocytes (Fig. 7d), suggesting that both
the increase in c-myc and mitochondrial proliferation depended on
PPARα. In order to examine whether the mitochondrial functional def-
icits may also be related to PPARα induction, complex I activity was
monitored by spectrophotometry. However, 2 weeks after administer-
ing Cre recombinase, loss of PEX5 was accompanied by reduced com-
plex I activity that was similar in a PPARα−/− (to 29 ± 7% of control)
and a PPARα+/+ background (to 31 ± 3% of control). Taken together,
the strong PPARα activation in peroxisome deﬁcient hepatocytes does
not underlie themitochondrial dysfunction but is involved in the prolif-
erative response.
4. Discussion
The communication between cellular compartments (like mito-
chondria and peroxisomes) and their interdependence is currently
still only poorly understood. We previously documented that peroxi-
some dysfunction in murine Pex5−/− hepatocytes severely impacts on
the mitochondrial inner membrane with loss and structural changes
of cristae and selective impairment of some but not all activities of
OXPHOS complexes [21,24]. The key novel ﬁndings of our study are:
1) mitochondrial membranes display altered physicochemical
properties; 2) respiratory complexes are differentially depleted or in-
completely assembled; 3) mtDNA is reduced leading to an imbalance
between mitochondrial- and nuclear-encoded subunits; and 4) the
compensatory increase of themitochondrial compartment is not driven
by classic PGC-1α signaling but mediated by PPARα.
Whereas metabolism in the mitochondrial matrix was preserved
and even increased in Pex5−/− hepatocytes [26], the architecture, func-
tion and lipid composition of the innermembranewas severely disorga-
nized. By using blue native gel electrophoresis and in-gel activity
analysis, we showed that the abundance of protein in the respiratory
complexes I and III was respectively moderately and strongly reduced
and that themajority of complex Vwas incompletely assembled. It is re-
markable that the activity of complex I (NADH:ubiquinone reductase)
was decreased to a larger extent using spectrophotometric analysis
(b30% of controls) than using in-gel activity measurements. However,
it should be noted that these techniques rely on different enzymatic
evaluations of complex I. The spectrophotometric assay measures the
complete electron transfer in complex I, i.e. from the substrate NADH
to co-enzyme Q. In contrast, the in-gel activity staining of complex I
only evaluates the ﬁrst part of this electron transfer cascade as a hydro-
gen and electrons from NADH are transferred to nitro blue tetrazolium
by the action of the ﬂavoprotein subunits located at the peripheral
arm of complex I. Furthermore, it has been demonstrated that the CoQ
binding site is situated at the interface between the membrane section
containing the mtDNA encoded subunits and the peripheral arm of
complex I. Importantly, also in patients with mutations in mtDNA-
encoded subunits of complex I, the same discrepancy between these
two assays has been reported [57,58]. Therefore, spectrophotometry
is better suited to detect defects in the mtDNA encoded subunits of
complex I.
The question arises what the precise sequence of events is at the
inner mitochondrial membrane. It is indeed unclear whether the loss
or assembly defects of the respiratory complex elicited the malforma-
tion of cristae or whether membrane anomalies prevented the integra-
tion of respiratory complexes. With regard to the ﬁrst possibility,
studies in yeast documented that defective complex assembly can im-
pair cristae formation. For example, ATP synthase occurs as long rows
of dimers at cristae ridges and the inability to dimerize results in the for-
mation of mitochondria with onion-like cristae [59,60]. In addition,
complete loss of mtDNA in the rho0 mutants causes structural mito-
chondrial distortions [61] that remarkably resemble those seen in theisolatedmitochondria from Pex5mutantmice. In PEX5deﬁcient hepato-
cytes, the mtDNA copy number per mitochondrion was estimated to be
reduced to approximately 15–20%, taking into account the 50% reduced
levels ofmtDNA/nuclear DNA and the substantial increase inmitochon-
drial mass (~3 fold). The ensuing decreased levels of mitochondrially-
encoded OXPHOS subunits is expected to impair the respiratory com-
plex assembly, which may in turn compromise cristae formation. In
particular, for complex V, the two mitochondrially-encoded subunits,
a and A6L, are part of the F0 domain embedded in the inner membrane
and are necessary for the connection with the catalytically active F1
domain [29]. It was shown that tissues from patients withmtDNA alter-
ations, including mutations in the mitochondrially-encoded ATP6 or
ATP8 genes, mutations in mitochondrially-encoded tRNA's, speciﬁc
mtDNA deletions and ﬁnally withmtDNAdepletion, contain catalytical-
ly active subcomplexes of complex V visible by in-gel ATPase activity
analysis [29,43]. This is similar to our ﬁndings in peroxisome-deﬁcient
hepatocytes where complex V almost exclusively occurs as incomplete
subcomplexes concurring with the loss of mtDNA. The intact activity
of complex II that contains nomitochondrially encoded subunits further
supports the possibility that mtDNA defects are the source of the anom-
alies. Conversely, complex IV activity was also unaffected when tested
by spectrophotometric and in-gel activity analysis albeit the mobility
seemed to be reduced. Yet, complex IV depends on 3 mtDNA subunits
(COX1-3) questioning how it can assemble and function properly.
However, the most pertinent question in this scenario is how inac-
tive peroxisomes can affect mtDNA. A possible mechanism is through
the production of oxidative stress as it is well known that ROS can
impair mitochondrial DNA integrity and dysfunctional peroxisomes
might be a source of ROS species [4]. Interesting in this respect, exces-
sive oxidative stress generated in peroxisomes increases the mitochon-
drial but not the cytosolic redox state [5]. It was also reported that lack
of ABCD1, a peroxisomal transporter of β-oxidation substrates, causes
oxidative damage to mitochondrial proteins leading to reduced activity
of ATP synthase but not of other OXPHOS complexes in the spinal cord
[62]. It is, however, unclear whether in conditions of peroxisome
biogenesis defects, in which both the ROS generating oxidases and the
ROS degrading enzymes such as catalase are absent from peroxisomes,
ROS species are increased in the cell. Previously, we did not ﬁnd
evidence for increased cellular oxidative stress in Pex5 deﬁcient hepato-
cytes [24] whereaswe now demonstrated an increase in the redox state
of mitochondria. Unfortunately, we could not pinpoint whether this
derives from local superoxide production. Indeed, the ﬂuorescence
signal using the MitoSOX Red assay was markedly reduced but this
may be an underestimation due to the low mitochondrial membrane
potential that impairs uptake of the probe [63]. In addition, the deple-
tion of mtDNA in Pex5 deﬁcient hepatocytes may further weaken the
ﬂuorescent signal of the oxidized probe, as this is strongly enhanced
by binding to DNA [63]. Therefore, it remains an open questionwhether
the increased redox state of mitochondria is a cause or a consequence of
OXPHOS disturbances.
In the alternative hypothesis, peroxisome dysfunction initially
causes amorphological insult at the innermembrane preventing the in-
tegration of OXPHOS complexes that subsequently are inactive and/or
disintegrate. The putative triggering factor could be an imbalance of
lipids as a result of impaired peroxisomalmetabolism. This could for ex-
ample explain the presence of the catalytically active F1 domain of com-
plex V that resides in the matrix while the transmembrane subunits a
and A6L cannot be incorporated in the membrane due to lipid alter-
ations preventing the formation of the holocomplex. The conserved
activity of the small complex II, consisting of only 4 subunits and not in-
tegrally embedded in the innermembrane, could be a notable exception
as it may remain stable when not properly inserted in the membrane.
Again, the normal activity of the large complex IV in spectrophotometric
analyses is difﬁcult to reconcile with this mechanism as the majority of
its subunits are transmembrane proteins of the inner membrane.
According to this rationale, the loss of mtDNA must also be secondary
296 A. Peeters et al. / Biochimica et Biophysica Acta 1853 (2015) 285–298to the innermembrane perturbation. The mitochondrial genome that is
packaged in nucleoids [64] is tethered to the inner membrane [65,66],
and it is plausible that the extensive distortion of the inner membrane
precludes attachment of the mitochondrial genome, leading to its loss.
Interestingly, in some rare cases of inborn errors of metabolism, muta-
tions in enzymes involved in lipidmetabolismwere shown to causemi-
tochondrial deﬁcits including loss of mtDNA. Examples are MEGDHEL
syndrome due to mutations in SERAC1, involved in phospholipid
remodeling and intracellular cholesterol transport [67], Megaconial
Congenital Muscular Dystrophy (MDCMC) caused by choline kinase B
deﬁciency [68] and Sengers syndrome due to a lack of acylglycerolkinase
[69,70].
The altered mitochondrial membrane features in peroxisome deﬁ-
cient liver are further characterized by increased permeability and ﬂuid-
ity. The marked reduction of the poly-unsaturated fatty acid DHA, a
product of peroxisomal β-oxidation, in all phospholipid species includ-
ing cardiolipin is in fact in disagreement with increased membrane
ﬂuidity. However, the decreased cholesterol/phospholipid ratio and
the loss of respiratory complexes may also contribute to the altered
membrane characteristics. Another apparently controversial observa-
tion is that, despite an extensive loss of the potential over the inner
membrane previously observed in cultured hepatocytes [24] and now
in isolated mitochondria, matrix enzymes can still be imported. For
example, the mt-roGFP2 probe used to study the intramitochondrial
redox balance was efﬁciently imported into the organelle. In addition,
the activities of the mitochondrial matrix proteins GDH and CS were
even increased, reﬂecting the larger mitochondrial mass. Note that
these observations are in accordance with previous ﬁndings in mtDNA-
deﬁcient rho0 mutants, in which the import and activity of nuclear-
encoded proteins is unaffected [61].
Besides enhanced activity of matrix enzymes, the expansion of the
mitochondrial compartment in peroxisome deﬁcient hepatocytes was
also illustrated by increased organelle numbers and by increased pro-
tein content in the mitochondrial fraction. This mitochondrial expan-
sion seemed to be a compensatory response as was also observed in
other conditions of mtDNA depletion [71] or defects in mitochondrial
respiratory function [72]. Proliferation appeared to be a prompt reaction
after acute PEX5 elimination as it occurred concomitant with loss
of functional peroxisomes and disruption of the inner membrane. In
view of the strong proliferative response, it is most surprising and
puzzling that levels of PGC-1α, the master regulator of mitochondrial
biogenesis in conditions of energy deﬁcits, are markedly reduced [25].
The family members PGC-1β and PGC-1-related coactivator (PRC)
were normally expressed or only slightly induced, not likely to steer
proliferation. Therefore, other factors must drive the increased genera-
tion of mitochondria. c-MYC is a good candidate as it was reported to
induce mitochondrial biogenesis [73,74] and in addition is a PPARα
target gene that was strongly induced in PEX5 deﬁcient liver. This
assumption is supported by the absence of c-myc induction and mito-
chondrial proliferation after acute elimination of PEX5 in a PPARα deﬁ-
cient background. In other conditions of mitochondrial damage [75,76],
increased expression of the transcription factors NRF-1/NRF-2, that play
an integrative role in the bigenomic expression of mitochondrial pro-
teins, and their target Tfam, that is essential formtDNA transcription ini-
tiation, was shown to enhance OXPHOS. Remarkably, no consistent
upregulation of these factors was observed at the RNA level in hepato-
cytes with either acute or chronic deletion of PEX5. Thus, the mecha-
nisms governing the increase of mitochondrial volume in peroxisome
deﬁcient hepatocytes as a compensation for respiratory dysfunction
deviate from those in other conditions of cellular energy deﬁcits. In
particular, the coordinate induction of the mitochondrial and nuclear-
encoded proteins seems to fail. At present, it cannot be excluded that
the enlarged mitochondrial volume is in part also due to impaired
mitophagy, a possibility that needs investigation.
In conclusion, we showed that inactive peroxisomes in hepatocytes
impact the mitochondrial genome, the physicochemical properties ofthe inner membrane, OXPHOS complexes, and the mitochondrial
redox state. The triggering factors arising from inactive hepatic
peroxisomes and the precise sequence of events in the affected mito-
chondria need to be further clariﬁed. This is of importance as hepatic
pathology, including hepatomegaly and ﬁbrosis, is a cardinal feature
in Zellweger syndrome, the prototype peroxisome biogenesis disor-
der. This hepatopathy may originate from the mitochondrial and not
peroxisomal metabolic deﬁcits.
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